Genuinely hopeful for a positive response on accelerated approval of aGVHD in FDAs formal letter coming up. The children and their families deserve this news.
Fantastic strategic development with the Novartis partnership deal though. This paves the way for what looks to be high certainty that we're getting positive, ground breaking outcomes from the COVID ARDS trial
"the third and final interim analysis, when 60 per cent of the patient cohort has completed 30 days of follow-up, will happen in the coming weeks"
I mean, the announcement of this strategic partnership almost certainly cements the news doesn't it?
Coupled with the upcoming P3 LBP and CHF results, you could not ask for a more exciting period for MSB leading up to Christmas.
Genuine well done to the patient, dedicated holders. Onwards and upwards all
- Forums
- ASX - By Stock
- Ann: Novartis and Mesoblast Remestemcel-L Collaboration
Genuinely hopeful for a positive response on accelerated...
-
- There are more pages in this discussion • 662 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9996 | 99.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.5¢ | 18069 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9996 | 0.990 |
2 | 32880 | 0.985 |
4 | 71034 | 0.980 |
2 | 3059 | 0.975 |
7 | 145890 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
0.995 | 1132 | 1 |
1.000 | 9500 | 3 |
1.005 | 35000 | 1 |
1.010 | 58113 | 4 |
1.015 | 46100 | 3 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online